Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...
AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...
Alcohol consumption can elevate cancer risk through mechanisms such as DNA damage, hormonal changes, and oxidative stress, with risks increasing alongside consumption levels.
In recent years, scientists and biohackers have sought out ways to "reset" our epigenetic clocks in order to slow down the aging process. This latest study, published in Nature Aging, however, ...
Their study showed that DCIS patients with pathogenic variants in BRCA1/2 and PALB2 had a higher risk of developing invasive breast cancer than those without.
Around 25,000 Kiwis are diagnosed with some form of cancer each year, while 9500 die from it, making it our most lethal disease. Across New Zealand, teams of researchers are pushi ...